Insider Shareholders with Indirect Ownership of Crispr Therapeutics Ag (CRSP)
This section provides a comprehensive overview of the insiders with indirect ownership of Crispr Therapeutics Ag (CRSP). You can find the latest updates on their holdings.
CRISPR Therapeutics AG Insider List
| Insider | Adquired | Disposed | # of Trades |
|---|---|---|---|
|
Celgene Corp /De/
> 10% Shareholder |
0 | 1,112,446 | 21 |
|
Sven Ante Lundberg
Chief Scientific Officer |
400 | 0 | 1 |
|
Kurt Von Emster
Director |
2,667,748 | 1,506,400 | 41 |
|
N Anthony Coles
Director |
70,000 | 0 | 1 |
| 4,269,578 | 0 | 2 | |
|
Thomas Woiwode
Director |
7,073,669 | 3,748,443 | 12 |
| 14 | 0 | 1 | |
|
Versant Venture Capital V, L.P.
> 10% Shareholder |
0 | 22,841 | 1 |
|
Glaxosmithkline Plc
> 10% Shareholder |
3,220,627 | 0 | 1 |
|
Bradley J Ph D Bolzon
Director |
7,923,484 | 8,364,019 | 38 |
|
Versant Venture Capital Iv, L.P.
> 10% Shareholder |
564,970 | 3,309,069 | 6 |
|
Aktiengesellschaft Bayer
> 10% Shareholder |
527,472 | 0 | 1 |